Dr. Agarwal’s Health Care Limited has announced its unaudited financial results for the second quarter and first half of fiscal year 2027, ending September 30, 2026. The presentation, delivered during an analyst and earnings conference call on November 5, 2026, details the company’s performance, operational updates, and financial standing. Key performance indicators and strategic initiatives are expected to be discussed, providing stakeholders with an overview of the company’s trajectory.
Dr. Agarwal’s Health Care Presents Q2 and H1 FY27 Financial Performance
Dr. Agarwal’s Health Care Limited has officially presented its unaudited financial results for the second quarter (Q2) and the first half (H1) of the fiscal year 2027, which concluded on September 30, 2026. The detailed presentation was shared on November 5, 2026, coinciding with the company’s analyst and earnings conference call.
Key Highlights from the Presentation
The presentation encompasses both standalone and consolidated financial results, offering a comprehensive view of the company’s performance. Key areas covered include:
- Performance Snapshot: An overview of the company’s operational and financial achievements during the period.
- Business Updates: Information on recent developments, expansion plans, and strategic initiatives.
- Financial Performance Update: Detailed analysis of revenue, profitability, and other financial metrics.
- About the Company: Insights into Dr. Agarwal’s Health Care’s business model, network, and market position.
- Overview of Eye Care Industry: Market trends and the company’s standing within the broader eye care sector.
The presentation materials are accessible on the company’s official website at https://dragarwals.co.in/#financials/analyst-earnings-call.
Financial Overview – H1’FY27
For the H1’FY27 period, Dr. Agarwal’s Health Care reported:
- Revenue from Operations: ₹1,269 Crore, marking a 28.7% YoY growth.
- IndAS EBITDA: ₹362 Crore, with a 27.0% YoY growth.
- Profit After Tax: ₹112 Crore, reflecting a substantial 50.1% YoY growth.
Operational Overview – H1’FY27
Operationally, the company served 1,844K+ Patients, performed 186K+ Surgeries, and maintained a network of 1,110+ Doctors and 2,400+ Paramedics across 324 Eye Care Facilities. The number of facility additions was 39 during this period.
Geographic Footprint and Clinical Excellence
The company’s geographic footprint spans across India and Africa, with a significant presence in South India (200 facilities) contributing 62.4% to its H1’FY27 revenue mix. The presentation also highlighted clinical advancements, including specialized surgical procedures like Femto Cataracts and Lenticular Procedures, along with investments in advanced ophthalmic equipment.
Growth Strategies
Dr. Agarwal’s Health Care continues to focus on organic growth through facility additions and expanding its service offerings. The company emphasizes its scalable, asset-light, hub-and-spoke operating model and a proven track record in organic growth and acquisitions.
Source: BSE
